Aptamer 学术简报 — neurodegeneration — 2026-11-15
自动生成 by RBTX Aptamer Tracker v0.1。 子主题 neurodegeneration:近 14 天 6 篇命中(aptamer 池 221 篇)。
评分公式:composite = 0.45×log(IF) + 0.35×log(cites_velocity) + 0.10×social + 0.10×recency_bonus;满分 100。
#1 [13.0] Nucleic Acid Amplification Boosts Electrochemically Addressable Probe Networks for Ultrasensitive Plate-Based Electrochemiluminescence Immunoassays
- Journal: Analytical Chemistry (IF 6.7)
- Date: 2026-11-12 · Citations: 0
- Authors: Tengyu Li, Yu Liang, Ziyang Wang et al. (12 authors)
- DOI: 10.1021/acs.analchem.6c06045
- Score components: IF 8.9 · recency 90.0
Abstract Electrochemiluminescence immunoassays (ECLIAs) offer low-background and highly sensitive protein biomarker detection, but their performance is often severely limited by the poor electrochemical accessibility of luminophore labels in bulky immunocomplexes. Herein an electrochemically addressable probe network-based ECL immunoassay (EAPN-...
#2 [11.4] Chemical design principles governing receptor-mediated blood-brain barrier transcytosis: analysis of 563 molecular shuttles.
- Journal: RSC advances (IF 3.9)
- Date: 2026-11-10 · Citations: 0
- Authors: Abbrederis N, Petersen MH, Møller CV et al. (6 authors)
- DOI: 10.1039/d6ra08288b · PMID: 43011777
- Score components: IF 6.9 · recency 83.3
The blood-brain barrier (BBB) remains a major obstacle to central nervous system drug delivery. Receptor-mediated transcytosis offers a promising strategy, motivating diverse molecular shuttle designs. Here, we systematically analyse 563 chemically defined BBB shuttles, comprising peptides (229), aptamers (149), antibodies (114), nanobodies (11)...
#3 [11.3] Magnetic-assisted catalytic hairpin assembly fluorescent aptasensor for highly sensitive detection of amyloid-beta oligomers as Alzheimer's disease biomarker.
- Journal: Analytica chimica acta (IF 5.4)
- Date: 2026-11-08 · Citations: 0
- Authors: Chen CH, She BC, Chen YL et al. (5 authors)
- DOI: 10.1016/j.aca.2026.346100 · PMID: 42763160
- Score components: IF 8.1 · recency 76.7
BACKGROUND: The abnormal accumulation of amyloid-beta peptides is a key contributor to Alzheimer's disease. Of these peptides, soluble amyloid-beta oligomers (AβOs) have emerged as potent neurotoxins and early pathological biomarkers. Although AβOs are highly specific biomarkers, their low physiological abundance, structural heterogeneity and ma...
#4 [11.1] CRISPR-enabled ultrasensitive surface-enhanced Raman scattering sensing platform for background-free detection of phosphorylated tau in Alzheimer's disease.
- Journal: Biosensors & bioelectronics (IF 10.7)
- Date: 2026-11-04 · Citations: 0
- Authors: Chen X, Yang Y, Liao Y et al. (10 authors)
- DOI: 10.1016/j.bios.2026.119400 · PMID: 43002967
- Score components: IF 10.7 · recency 63.3
Accurate and ultrasensitive detection of phosphorylated tau at threonine 231 (P-tau231), a pathologically validated early biomarker of Alzheimer's disease (AD), is essential for preclinical diagnosis and longitudinal monitoring. However, blood-based detection remains challenging because of the femtomolar physiological abundance, substantial inte...
#5 [11.0] An Electrochemiluminescence Biosensing Platform Based on a Hydrogel-AAO Nanochannel Membrane for GFAP Detection
- Journal: ACS Sensors (IF 8.2)
- Date: 2026-11-05 · Citations: 0
- Authors: Junjie Lai, Jiaming Chen, Hongyang Huang et al. (8 authors)
- DOI: 10.1021/acssensors.6c03340
- Score components: IF 9.6 · recency 66.7
Abstract Electrochemiluminescence (ECL) biosensors are widely used for ultrasensitive bioanalysis; however, their practical application is often limited by insufficient interface stability under complex detection conditions. Herein, an integrated hydrogel-AAO membrane (HAM) as a novel composite ion-exchange membrane is developed for constructing...
#6 [6.7] CRISPR-Cas Assays for Protein Detection: Strategies and Clinical Applications.
- Journal: Small methods (IF ?)
- Date: 2026-11-05 · Citations: 0
- Authors: Dong S, Zhao S, Deng J et al. (5 authors)
- DOI: 10.1002/smtd.71186 · PMID: 42985920
- Score components: recency 66.7
Measurement of protein biomarkers with high accuracy is critical for disease diagnostics and prognostic monitoring. However, conventional analytical platforms for protein detection suffer from insufficient sensitivity for low-abundance targets and require time-consuming, multi-step workflows. The CRISPR-Cas system is emerging as a powerful tool ...
Methodology
- 数据源:PubMed (esearch + esummary), OpenAlex (concept C2776201186 + DOI 反查 citations), bioRxiv (preprints)
- 去重:按 DOI 跨源合并
- IF:硬编码 top 50 期刊 JCR 2024 IF(
config.JOURNAL_IF) - Citation velocity:OpenAlex
cited_by_count/ 发表天数 - Social:Reddit r/science + r/biotech + HN(DOI/title 关键词搜)
- 窗口:近 14 天发表;超出 30 天 recency_bonus = 0
- 每天:建议 8-9am 跑
python run.py collect && python run.py score && python run.py report